Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
6.23
+0.12 (1.96%)
Oct 8, 2025, 4:00 PM EDT - Market closed
Nuvectis Pharma Market Cap
Nuvectis Pharma has a market cap or net worth of $158.60 million as of October 8, 2025. Its market cap has increased by 30.81% in one year.
Market Cap
158.60M
Enterprise Value
131.80M
1-Year Change
30.81%
Ranking
Category
Stock Price
$6.23
Market Cap Chart
Since the IPO on February 4, 2022, Nuvectis Pharma's market cap has increased from $58.01M to $158.60M, an increase of 173.42%. That is a compound annual growth rate of 31.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 155.54M | 48.81% |
| Dec 31, 2024 | 104.53M | -27.67% |
| Dec 29, 2023 | 144.50M | 31.58% |
| Dec 30, 2022 | 109.82M | 89.32% |
| Feb 4, 2022 | 58.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 760.18B |
| Johnson & Johnson | 452.24B |
| AbbVie | 404.59B |
| UnitedHealth Group | 325.91B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 232.30B |